- Home
- IMRX vs FLYX Comparison
IMRX vs FLYX Comparison
Compare IMRX & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- FLYX
- Stock Information
- Founded
- IMRX 2008
- FLYX 2015
- Country
- IMRX United States
- FLYX United States
- Employees
- IMRX N/A
- FLYX N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- FLYX Blank Checks
- Sector
- IMRX Health Care
- FLYX Finance
- Exchange
- IMRX Nasdaq
- FLYX Nasdaq
- Market Cap
- IMRX 52.2M
- FLYX 60.0M
- IPO Year
- IMRX 2021
- FLYX N/A
- Fundamental
- Price
- IMRX $1.87
- FLYX $3.30
- Analyst Decision
- IMRX Strong Buy
- FLYX
- Analyst Count
- IMRX 3
- FLYX 0
- Target Price
- IMRX $15.33
- FLYX N/A
- AVG Volume (30 Days)
- IMRX 240.9K
- FLYX 7.7K
- Earning Date
- IMRX 05-05-2025
- FLYX 05-13-2025
- Dividend Yield
- IMRX N/A
- FLYX N/A
- EPS Growth
- IMRX N/A
- FLYX N/A
- EPS
- IMRX N/A
- FLYX N/A
- Revenue
- IMRX N/A
- FLYX $335,427,000.00
- Revenue This Year
- IMRX N/A
- FLYX $28.47
- Revenue Next Year
- IMRX N/A
- FLYX $22.44
- P/E Ratio
- IMRX N/A
- FLYX N/A
- Revenue Growth
- IMRX N/A
- FLYX 5.38
- 52 Week Low
- IMRX $1.00
- FLYX $1.79
- 52 Week High
- IMRX $3.83
- FLYX $6.22
- Technical
- Relative Strength Index (RSI)
- IMRX 68.56
- FLYX 63.58
- Support Level
- IMRX $1.58
- FLYX $2.60
- Resistance Level
- IMRX $1.85
- FLYX $3.39
- Average True Range (ATR)
- IMRX 0.15
- FLYX 0.20
- MACD
- IMRX 0.05
- FLYX 0.05
- Stochastic Oscillator
- IMRX 97.20
- FLYX 89.06
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.